Evidence map›Paper›PMID 29412700›Full record

ArticleAmerican journal of physiology. Renal physiology2018

Lineage tracing aged mouse kidneys shows lower number of cells of renin lineage and reduced responsiveness to RAAS inhibition.

Hiroko Hamatani, Diana G Eng, Natalya V Kaverina, Kenneth W Gross, Benjamin S Freedman, Jeffrey W Pippin, Stuart J Shankland

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in American journal of physiology. Renal physiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Molecular Mechanisms Associated with Aging Kidneys and Future Perspectives.International journal of molecular sciences · 2023
    Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Cells of NG2 lineage increase in glomeruli of mice following podocyte depletion.American journal of physiology. Renal physiology · 2018
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Hiroko HamataniDivision of Nephrology, University of Washington School of Medicine , Seattle, Washington.
Diana G EngDivision of Nephrology, University of Washington School of Medicine , Seattle, Washington.
Natalya V KaverinaDivision of Nephrology, University of Washington School of Medicine , Seattle, Washington.
Kenneth W GrossDepartment of Molecular and Cellular Biology, Roswell Park Cancer Institute , Buffalo, New York.
Benjamin S FreedmanDivision of Nephrology, University of Washington School of Medicine , Seattle, Washington.
Jeffrey W PippinDivision of Nephrology, University of Washington School of Medicine , Seattle, Washington.
Stuart J ShanklandDivision of Nephrology, University of Washington School of Medicine , Seattle, Washington.
University of Washington · USRoswell Park Comprehensive Cancer Center · US

Funding

Two-Spirit Films in Indigenous Cancer HealthP30CA016056 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI Dean G. Tang · 1985 to 2026
$116.6M
Juxta-glomerular cells serve as glomerular epithelial cell progenitors in glomerular diseaseR01DK097598 · NIDDK · UNIVERSITY OF WASHINGTON · PI SHANKLAND, STUART JAMES, WESSELY, OLIVER · 2014 to 2022
$5.2M
RENIN-EXPRESSING CELL LINES FOR HYPERTENSION RESEARCHR01HL048459 · NHLBI · ROSWELL PARK CANCER INSTITUTE CORP · PI GROSS, KENNETH W · 1992 to 2010
$4.2M
Reduced Glomerular Progenitors Impair Regeneration in Aged KidneyR01AG046231 · NIA · UNIVERSITY OF WASHINGTON · PI SHANKLAND, STUART JAMES · 2016 to 2020
$2.6M
Modeling Polycystic Kidney Disease Using Human Induced Pluripotent Stem CellsK01DK102826 · NIDDK · UNIVERSITY OF WASHINGTON · PI FREEDMAN, BENJAMIN SOLOMON · 2014 to 2018
$743k
NCI NIH HHS P30 CA016056NHLBI NIH HHS R01 HL048459NIA NIH HHS R01 AG046231NIDDK NIH HHS K01 DK102826NIDDK NIH HHS R01 DK097598
6 · The paper itself

Abstract

Blocking the renin-angiotensin-aldosterone system (RAAS) remains a mainstay of therapy in hypertension and glomerular diseases. With the population aging, our understanding of renin-producing cells in kidneys with advanced age is more critical than ever. Accordingly, we administered tamoxifen to Ren1cCreERxRs-tdTomato-R mice to permanently fate map cells of renin lineage (CoRL). The number of Td-tomato-labeled CoRL decreased significantly in aged mice (24 mo of age) compared with young mice (3.5 mo of age), as did renin mRNA levels. To determine whether aged CoRL responded less to RAAS blockade, enalapril and losartan were administered over 25 days following uninephrectomy in young and aged mice. The number of CoRL increased in young mice in response to enalapril and losartan. However, this was significantly lower in aged mice compared with young mice due to limited proliferation, but not recruitment. Gene expression analysis of laser-captured CoRL showed a substantial increase in mRNA levels for proapoptotic and prosenescence genes, and an increase in a major prosenescence protein on immunostaining. These results show that CoRL are lower in aged mice and do not respond to RAAS inhibition to the same extent as young mice.

Indexed as

Cell LineageAge FactorsAgingAngiotensin-Converting Enzyme InhibitorsAngiotensin II Type 1 Receptor BlockersAnimalsApoptosisBlood PressureCell ProliferationCellular SenescenceEnalaprilFemaleGenes, ReporterKidneyLosartanLuminescent ProteinsAngiotensin-Converting Enzyme InhibitorsAngiotensin II Type 1 Receptor BlockersEnalaprilLosartanLuminescent ProteinsRed Fluorescent ProteinReninapoptosisglomerulusjuxta-glomerulusproliferationsenescence

Identifiers

PMID29412700
PMCPMC6087792
OpenAlexW2787164704

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.